Evidence map›Paper›PMID 41104927›Full record

ArticlemSystems2025

DNA reference reagents isolate biases in microbiome profiling: a global multi-lab study.

Saba Anwar, Matthew Lamaudiere, Jack Hassall, Jacob Dehinsilu, Ravneet K Bhuller, Georgina L Hold, Xabier Vázquez-Campos, Alexander Mahnert, Christine Moissl-Eichinger, Birgit Gallé and 94 more

Abstract read
In one paragraph

Article in mSystems, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Review
  6. Emerging technologies and current challenges in intratumoral microbiota research.Frontiers in cellular and infection microbiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

104 authors.

Saba Anwar *Medicines and Healthcare Products Regulatory Agency, London, United Kingdom.ORCID 0009-0002-4725-2793
Matthew Lamaudiere *Medicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Jack HassallMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Jacob DehinsiluMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Ravneet K BhullerMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Georgina L HoldUNSW Microbiome Research Centre, St George Hospital, Kogarah, New South Wales, Australia.ORCID 0000-0001-7573-3397
Xabier Vázquez-CamposNSW Systems Biology Initiative, School of Biotechnology and Biomolecular Sciences, University of New South Wales, Sydney, New South Wales, Australia.ORCID 0000-0003-1134-5058
Alexander MahnertDiagnostic & Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0001-7083-8894
Christine Moissl-EichingerDiagnostic & Research Institute of Hygiene, Microbiology and Environmental Medicine, Medical University of Graz, Graz, Austria.ORCID 0000-0001-6755-6263
Birgit GalléCore Facility Molecular Biology, Center for medical research, Medical University of Graz, Graz, Austria.
Gudrun KainzCore Facility Molecular Biology, Center for medical research, Medical University of Graz, Graz, Austria.
Petra PjevacJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Bela HausmannJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Jasmin SchwarzJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Gudrun KohlJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
David BerryJoint Microbiome Facility of the Medical University of Vienna, University of Vienna, Vienna, Austria.
Sarah J VancurenDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
Emma Allen-VercoeDepartment of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.ORCID 0000-0002-8716-327X
Nynne NielsenClinical Microbiomics A/S, Copenhagen, Denmark.
Nikolaj SørensenClinical Microbiomics A/S, Copenhagen, Denmark.
Aron EklundClinical Microbiomics A/S, Copenhagen, Denmark.
Henrik Bjørn NielsenClinical Microbiomics A/S, Copenhagen, Denmark.
René RiedelGerman Rheumatology Research Center Berlin, A Leibniz Institute, Berlin, Germany.
Jannike Lea KrauseGerman Rheumatology Research Center Berlin, A Leibniz Institute, Berlin, Germany.ORCID 0000-0001-8514-9979
Hyun-Dong ChangGerman Rheumatology Research Center Berlin, A Leibniz Institute, Berlin, Germany.
Suenie ParkProbiotics Microbiome Convergence Center, Soonchunhyang University, Asan-si, South Korea.
Ho-Yeon SongProbiotics Microbiome Convergence Center, Soonchunhyang University, Asan-si, South Korea.
Hoonhee SeoProbiotics Microbiome Convergence Center, Soonchunhyang University, Asan-si, South Korea.
Asad Ul-HaqProbiotics Microbiome Convergence Center, Soonchunhyang University, Asan-si, South Korea.
Sukyung KimProbiotics Microbiome Convergence Center, Soonchunhyang University, Asan-si, South Korea.
Yongbin KwonBiowaveW, Seoul, South Korea.
Sunwha ParkBiowaveW, Seoul, South Korea.
Xavier SoberonUnidad de Vinculación Cientifica UNAM-INMEGEN, Instituto Nacional de Medicina Genomica, Mexico, Mexico.
Eugenia Silva-HerzogUnidad de Vinculación Cientifica UNAM-INMEGEN, Instituto Nacional de Medicina Genomica, Mexico, Mexico.
Joost A M VerlouwLaboratory of Population Genomics, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Pascal ArpLaboratory of Population Genomics, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Mila JhamaiLaboratory of Population Genomics, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Robert KraaijLaboratory of Population Genomics, Department of Internal Medicine, Erasmus University Medical Center, Rotterdam, the Netherlands.
Anoecim R GeelenCenter for Microbiome Analyses and Therapeutics, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
Quinten R DucarmonCenter for Microbiome Analyses and Therapeutics, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.
Wiep Klaas SmitsCenter for Microbiome Analyses and Therapeutics, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-7409-2847
Ed J KuijperCenter for Microbiome Analyses and Therapeutics, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0001-5726-2405
Romy D ZwittinkCenter for Microbiome Analyses and Therapeutics, Department of Medical Microbiology, Leiden University Medical Center, Leiden, the Netherlands.ORCID 0000-0002-0537-6838
Niels van BestDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
John PendersDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Giang LeDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Christel DriessenDepartment of Medical Microbiology, Infectious Diseases and Infection Prevention, School for Nutrition and Translational Research in Metabolism, Maastricht University, Maastricht, the Netherlands.
Jolanda KoolCenter for infectious disease control, Dutch National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Sudarshan A ShettyCenter for infectious disease control, Dutch National Institute for Public Health and the Environment, Bilthoven, the Netherlands.
Susana FuentesCenter for infectious disease control, Dutch National Institute for Public Health and the Environment, Bilthoven, the Netherlands.ORCID 0000-0002-9455-4965
Mehmet DemirciDepartment of Medical Microbiology, Faculty of Medicine, Kırklareli University, Kırklareli, Turkey.ORCID 0000-0001-9670-2426
Akin YiginDepartment of Genetics, Faculty of Veterinary Medicine, Harran University, Şanlıurfa, Turkey.
Celina WhalleyGenomics Birmingham, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Andrew D BeggsGenomics Birmingham, Institute of Cancer & Genomic Sciences, University of Birmingham, Birmingham, United Kingdom.
Christopher QuinceEarlham Institute and Quadram Institute Bioscience, Norwich, United Kingdom.
Rob JamesEarlham Institute and Quadram Institute Bioscience, Norwich, United Kingdom.
Sebastien RaguideauEarlham Institute and Quadram Institute Bioscience, Norwich, United Kingdom.
Martin GordonMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Ryan MateMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Martin FritzscheMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Nathan P DanckertImperial College London, London, United Kingdom.
Jesus Miguens BlancoImperial College London, London, United Kingdom.
Julian R MarchesiImperial College London, London, United Kingdom.
Marcus RauchAlphaBiomics Ltd., London, United Kingdom.
R Anthony WilliamsonAlphaBiomics Ltd., London, United Kingdom.
Angélique B Van't WoutAlphaBiomics Ltd., London, United Kingdom.
Angelika KritzSource BioScience UK LTD, Nottingham, United Kingdom.
Stephan RoseckerSource BioScience UK LTD, Nottingham, United Kingdom.
Richard StevensSource BioScience UK LTD, Nottingham, United Kingdom.
Lynette LawsSource BioScience UK LTD, Nottingham, United Kingdom.
Lizbeth SayavedraQuadram Institute Bioscience-Gut Microbes and Health Research Programme, Norwich, United Kingdom.ORCID 0000-0001-5814-9471
Stefano RomanoQuadram Institute Bioscience-Gut Microbes and Health Research Programme, Norwich, United Kingdom.
Andrea TelatinQuadram Institute Bioscience-Gut Microbes and Health Research Programme, Norwich, United Kingdom.ORCID 0000-0001-7619-281X
David BakerQuadram Institute Bioscience-Gut Microbes and Health Research Programme, Norwich, United Kingdom.
Arjan NarbadQuadram Institute Bioscience-Gut Microbes and Health Research Programme, Norwich, United Kingdom.
Stephanie L ServetasNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.
Jason G KraljNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.ORCID 0000-0003-4565-1176
Samuel P ForryNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.
Monique E HunterNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.
Jennifer N DootzNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.
Scott A JacksonNational Institute of Standards and Technology, Gaithersburg, Maryland, USA.
Christopher E MasonDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.ORCID 0000-0002-1850-1642
Daniel J ButlerDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Christopher MozsaryDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Jonathan FooxDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Namita DamleDepartment of Physiology and Biophysics, Weill Cornell Medicine, New York, New York, USA.
Aidan ReshDiversigen, Inc., New Brighton, Minnesota, USA.
Amanda BusswitzDiversigen, Inc., New Brighton, Minnesota, USA.
Peter LenzDiversigen, Inc., New Brighton, Minnesota, USA.
Shane SontagDiversigen, Inc., New Brighton, Minnesota, USA.
Andrew CrossDiversigen, Inc., New Brighton, Minnesota, USA.
Christian SanchezDiversigen, Inc., New Brighton, Minnesota, USA.
Mingsheng GuoDiversigen, Inc., New Brighton, Minnesota, USA.
Kayla OlsonDiversigen, Inc., New Brighton, Minnesota, USA.
Eric A SmithDiversigen, Inc., New Brighton, Minnesota, USA.
Alex J La ReauDiversigen, Inc., New Brighton, Minnesota, USA.
Tonya WardDiversigen, Inc., New Brighton, Minnesota, USA.
Scott KuerstenIllumina, Inc., San Diego, California, USA.ORCID 0009-0007-5058-4920
Fred HydeIllumina, Inc., San Diego, California, USA.
Irina KhrebtukovaIllumina, Inc., San Diego, California, USA.
Gary SchrothIllumina, Inc., San Diego, California, USA.
Sjoerd RijpkemaMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Gregory C A AmosMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.
Chrysi SergakiMedicines and Healthcare Products Regulatory Agency, London, United Kingdom.ORCID 0000-0003-0477-8680

Funding

Department of Health and Social Care (DHSC) Policy Research Programme (MHRA Regulatory Science Research Unit)DFG project 375876048 TRR241 B03Dr. Rolf M. Schwiete StiftungEFRE-Project 1.6./01: "BacFlow"Innovate UK Small Business Research Initiative Award for "Creating Standards for Microbiome Therapies"
6 · The paper itself

Abstract

When profiling the human gut microbiome, technical biases introduced by analytical approaches impede translational research, reducing data reliability and study comparability. Here, through a global study involving 23 labs, we analyzed a wide range of sequencing and bioinformatic approaches for the taxonomic profiling of two well-defined DNA reference reagents (RRs) comprised of 20 common gut bacteria. Through both shotgun and 16S rRNA gene amplicon sequencing, we aimed to isolate sources of bias and understand their impact on microbiome profiling accuracy. Importantly, minimum quality criteria (MQC) were established and are used to evaluate profiling performance. We found that the variability of shotgun sequencing data sets was greater than that of 16S rRNA gene amplicon sequencing and isolated sources of bias in wet and dry lab steps, such as sequencing depth, primer and database choices, rarefaction, and 16S copy number adjustment. This study presents well-defined RRs and MQC to combat technical bias, paving the way for reliable and comparable microbiome research.IMPORTANCEThis benchmark paper highlights the true level of variability in microbiome data across the world and across sectors, underscoring the critical need for the use of WHO International DNA Gut Reference Reagents (RRs) to elevate the quality of data in microbiome research. This global study is the first of its kind, revealing the reality of the bias in the field, comprehensively testing methodologies used by leading laboratories across the world, but also providing avenues for workflow optimization, to accelerate innovation and translational research and move the field forward.

Indexed as

BacteriaDNA, BacterialGastrointestinal MicrobiomeHigh-Throughput Nucleotide SequencingHumansMicrobiotaReference StandardsRNA, Ribosomal, 16SSequence Analysis, DNADNA, BacterialRNA, Ribosomal, 16Sgut microbiome

Identifiers

PMID41104927
PMCPMC12625696

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.